このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

ALS 患者の嚥下障害、QoL、および PEG に対する態度 (ALSDPEG)

筋萎縮性側索硬化症患者における嚥下障害、生活の質、および経皮的内視鏡的胃瘻造設に対する態度

In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.

調査の概要

詳細な説明

The purpose of this study is to monitor the deterioration of swallowing function in ALS patient population, and to explore its impact on QoL and attitudes toward PEG tube insertion and feeding in the course of the disease. It will take maximum of 60 minutes to fully evaluate the swallowing function and complete the questionnaires. The evaluation procedure will be repeated every 3 months until PEG tube insertion, which will allow us to closely monitor the swallowing function in a relation to attitudes toward PEG and QoL. The data obtained from this study should contribute significantly to the knowledge of QoL in ALS patients with dysphagia, and it will allow for a comparison of QoL in ALS patients with and without PEG tube. This study will also expand the understanding of attitudes in ALS patients and their relatives toward PEG, and the impact of those attitudes on the decision-making process.

研究の種類

観察的

入学 (推定)

60

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Ljubljana、スロベニア、1000
        • 募集
        • University Medical Centre Ljubljana
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The study will include adult ALS patients able to visit the study site for in-person procedures every 3 months, and their close relatives.

説明

Inclusion Criteria for patients:

  • 18 years of age or older
  • diagnosis of ALS
  • follow-up at University Medical Centre Ljubljana, Division of Neurophysiology, every 3 months
  • be able to visit the study site for in-person procedures every 3 months

Inclusion Criteria for relatives:

  • at least 18 years of age

Exclusion Criteria for patients:

  • co-existing illness or disorder that could influence the swallowing function independently of the ALS diagnosis
  • clinically significant cognitive deterioration or dementia at enrollment, as determined by the ALS study neurologist

Exclusion criteria for relatives:

  • signs of probable cognitive deterioration or dementia at enrollment

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
ALS Patients

Patients with confirmed amyotrophic lateral sclerosis.

IOPI measures the peak pressure of the tongue strength and endurance using a disposable bulb placed on a hard palate behind the front teeth or at the base of the tongue. The participants will be asked to press the bulb with their tongue with maximum pressure, three times. To measure the endurance, the participants will be asked to hold the pressure for as long as they can.

MASA is a standard clinical swallowing assessment protocol including general patient examination, on-the-outside visible signs of oral preparatory and transportation phase and pharyngeal phase of swallowing function.

The subjects will ingest up to 10 boluses ranging in thickness and volume (from thin to extremely-thick and a cookie).

Respiratory function measurements will include forced vital capacity (FVC), maximum inspiratory pressure (MIP), and maximum expiratory pressure (MEP), all expressed in percentage of predicted values. Conventional methods of testing will be applied.

Relatives

Close relatives of the patients included in the study.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Penetration-Aspiration Scale (PAS) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

PAS is an 8-point scale used to determine swallowing safety. Levels 1 and 2 are considered safe, levels >3 indicate penetration or aspiration and are considered unsafe.

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Yale Residue Severity Rating Scale (YRSRS) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

YRSRS is a validated measure of swallowing efficiency using an image-based assessment to determine post-swallow pharyngeal residue: location and severity. It is assessed using a 5-point ordinal scale (from 1=0 % residue to 5=50 % residue).

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Iowa Oral Performance Instrument (IOPI) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

IOPI is a device which measures tongue strength (in kilopascals; kPa) and endurance (in seconds) while the participant presses the bulb with the front or the base of their tongue to the hard palate.

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Mann Assessment of Swallowing Ability (MASA) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

MASA is a standard clinical swallowing assessment protocol administered by the speech-language therapist. Total score ranges from 38-200. Lower score indicates higher impairment.

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Eating Assessment Tool 10 (EAT-10) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

EAT-10 is a validated self-administered dysphagia severity symptom survey including 10 items and a five-point scale (0=no problem to 4=sever problem). Higher total score indicates higher impairment.

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Swallowing Quality of Life Questionnaire (SWAL-QoL) change
時間枠:At baseline and every 3 months until PEG insertion, 3 and 6 months after PEG insertion

SWAL-QoL is a 44-item standardised psychometric scale that measures swallowing-related QoL across 10 domains. Scores for each individual domain and a total SWAL-QoL score are calculated. Total score ranges from 0-100 (100 indicating the most favourable state).

At baseline and every 3 months until PEG insertion, 3 and 6 months after PEG insertion
Questionnaire on Attitudes Toward PEG Tube Feeding and Insertion Procedure change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

The questionnaire comprises 10 questions. The participants specify their level of agreement on a five-point Likert-type scale (1=strongly disagree, 5= strongly agree).

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

二次結果の測定

結果測定
メジャーの説明
時間枠
ALS Functional Rating Scale-Revised (ALSFRS-R) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

ALSFRS-R is a 12-tem ALS-specific assessment of global functioning using a five-point scale (0=not able, 4= normal ability), with 48 points representing normal function.

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Functional Oral Intake Scale (FOIS) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

FOIS is a validated 7-point scale demonstrating an individual's ability of daily oral food intake (1=no oral intake, 7=total oral intake with no restrictions).

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Dysphagia Outcome and Severity Scale (DOSS) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

DOSS is a 7-point scale that rates the functional severity of dysphagia based on objective assessment and provides information on diet recommendations, independence level and type of nutrition necessary (level 7=normal swallowing function, level 1=severe dysphagia).

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
BMI change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Body mass index (in kg/m^2)

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Forced Vital Capacity (FVC) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Standard clinical respiratory assessment of FVC (in %)

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Peak Cough Flow (PCF) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Standard clinical respiratory assessment of PCF (in L/min)

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Maximal Inspiratory Pressure (MIP) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Standard clinical respiratory assessment of MIP (in cmH2)

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Maximal Expiratory Pressure (MEP) change
時間枠:Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Standard clinical respiratory assessment of MEP (in cmH2)

Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Blaž Koritnik, MD, PhD、University Medical Centre Ljubljana

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2023年1月1日

一次修了 (推定)

2026年12月30日

研究の完了 (推定)

2026年12月30日

試験登録日

最初に提出

2022年3月16日

QC基準を満たした最初の提出物

2022年4月14日

最初の投稿 (実際)

2022年4月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月16日

QC基準を満たした最後の更新が送信されました

2026年11月13日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する